16,729 Shares in Cardlytics, Inc. (NASDAQ:CDLX) Purchased by Virtu Financial LLC

Virtu Financial LLC acquired a new position in shares of Cardlytics, Inc. (NASDAQ:CDLX) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 16,729 shares of the company’s stock, valued at approximately $62,000.

Several other hedge funds have also added to or reduced their stakes in the stock. Intech Investment Management LLC increased its stake in shares of Cardlytics by 31.3% during the 4th quarter. Intech Investment Management LLC now owns 19,310 shares of the company’s stock worth $72,000 after purchasing an additional 4,607 shares during the last quarter. BNP Paribas Financial Markets increased its position in Cardlytics by 32.1% in the third quarter. BNP Paribas Financial Markets now owns 19,745 shares of the company’s stock worth $63,000 after buying an additional 4,796 shares during the last quarter. SG Americas Securities LLC raised its stake in shares of Cardlytics by 38.2% in the fourth quarter. SG Americas Securities LLC now owns 19,490 shares of the company’s stock valued at $72,000 after buying an additional 5,392 shares during the period. Check Capital Management Inc. CA lifted its position in shares of Cardlytics by 11.0% during the 4th quarter. Check Capital Management Inc. CA now owns 56,200 shares of the company’s stock valued at $209,000 after buying an additional 5,550 shares during the last quarter. Finally, Global Retirement Partners LLC grew its stake in shares of Cardlytics by 54.7% during the 4th quarter. Global Retirement Partners LLC now owns 19,800 shares of the company’s stock worth $73,000 after acquiring an additional 7,000 shares during the period. Institutional investors own 68.10% of the company’s stock.

Cardlytics Stock Performance

NASDAQ CDLX opened at $1.82 on Tuesday. The company’s 50 day simple moving average is $2.78 and its two-hundred day simple moving average is $3.38. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.18 and a quick ratio of 1.18. Cardlytics, Inc. has a 1 year low of $1.77 and a 1 year high of $15.89. The stock has a market capitalization of $94.79 million, a PE ratio of -0.30 and a beta of 1.62.

Insider Buying and Selling

In related news, CFO Alexis Desieno sold 8,854 shares of the firm’s stock in a transaction that occurred on Friday, January 3rd. The shares were sold at an average price of $3.67, for a total value of $32,494.18. Following the sale, the chief financial officer now directly owns 121,976 shares of the company’s stock, valued at $447,651.92. This trade represents a 6.77 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Amit Gupta sold 46,857 shares of the business’s stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $3.40, for a total transaction of $159,313.80. Following the completion of the transaction, the chief executive officer now directly owns 418,637 shares of the company’s stock, valued at approximately $1,423,365.80. This represents a 10.07 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 111,454 shares of company stock worth $391,864. Corporate insiders own 4.40% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the stock. Lake Street Capital dropped their price objective on shares of Cardlytics from $5.00 to $3.00 and set a “hold” rating on the stock in a report on Thursday, March 13th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cardlytics in a report on Thursday, March 13th. Finally, Evercore ISI lowered their target price on shares of Cardlytics from $4.00 to $3.00 and set an “in-line” rating on the stock in a report on Thursday, March 13th. One research analyst has rated the stock with a sell rating, five have given a hold rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, Cardlytics presently has a consensus rating of “Hold” and an average target price of $6.42.

Cardlytics Profile

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.